ARTELO BIOSCIENCES, INC.
Last · NASDAQ$2.88-0.10 (-3.36%)close · yahoo · 15h ago
Market cap$1.58M547.8K sh
P/E · TTM-0.0fwd -3.3 · eps -140.64 · loss
Beta-0.07vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.82$179.19
Volume43.1Ksession
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-02-24
- Operating Cf Burn
- Cash Runway Low
- Current Ratio Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.1 years
- Current Ratio Low — Current ratio 0.17
Press & signals
- GlobeNewswire
Artelo Biosciences Announces Reverse Stock Split
- GlobeNewswire
Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
- GlobeNewswire
Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags